New breast cancer locator aims to reduce repeat surgeries

NCT ID NCT06461663

Completed Knowledge-focused Sponsor: CairnSurgical, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a custom-made device called the Breast Cancer Locator (BCL) in 35 women with non-palpable breast cancer. The device helps surgeons see exactly where the tumor is during breast-conserving surgery, with the goal of removing all cancer in one go and reducing the need for additional surgery. The study measured how often cancer cells were left behind and how much healthy tissue was removed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast carcinoma in situ breast neoplasm ductal breast carcinoma in situ invasive breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Agaplesion Markus Krankenhaus

Frankfurt, Germany
Breast Unit Heidelberg, St Elisabeth Hospital

Heidelberg, Germany
Ospedale Regionale di Bellinzona e Valli

Bellinzona, Switzerland
Spital Zollikerberg

Zurich, Switzerland
U.O. Senologia Ospedale Santa Chiara, Azienda Ospedaliera Universitaria Pisana

Pisa, Italy
U.O. Senologia, Instituto Clinico Humanitas

Milan, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.